Plus Therapeutics | CYTX - Nettoeinkommen

Aktienkurs
4.80
Täglich Wechseln
0.88 22.45%
Monatlich
-37.60%
Jährlich
-74.40%
Q2 Prognose
4.67




Nettoeinkommen Veränderung Datum
Baxter International USD -1.13B 1.08B 2025-12
Cerus USD -20.92M 17.98M 2024-12
Dr.Reddys Laboratories INR 12.1B 2.27B 2025-12
Haemonetics USD 44.74M 6.06M 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Northwest Biotherapeutics USD -27.18M 7.81M 2025-09
Plus Therapeutics USD -5.71M 1.29M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Starpharma Holdings AUD 1.37M 3.67M 2025-12
Sun Pharmaceuticals INR 33.69B 2.51B 2025-12
Teva Pharmaceutical Industries USD 480M 47M 2025-12